Safety of Rabeprazole in Patients Under Multiple Treatments

Stopped Due to the achievement of minimum required sample size and new changes in local regulations.

Conditions

• Gastroesophageal Reflux
• Gastric Ulcer

Interventions

• DRUG: Rabeprazol

Sponsor

Janssen-Cilag, S.A.